4-Hydroxy-1α,25-Dihydroxyvitamin D3: Synthesis and Structure-Function Study

Biomolecules. 2024 May 3;14(5):551. doi: 10.3390/biom14050551.

Abstract

The active vitamin D metabolites, 25-hydroxyvitamin D3 (25D3) and 1,25-dihydroxyvitamin D3 (1,25D3), are produced by successive hydroxylation steps and play key roles in several cellular processes. However, alternative metabolic pathways exist, and among them, the 4-hydroxylation of 25D3 is a major one. This study aims to investigate the structure-activity relationships of 4-hydroxy derivatives of 1,25D3. Structural analysis indicates that 1,4α,25(OH)3D3 and 1,4β,25(OH)3D3 maintain the anchoring hydrogen bonds of 1,25D3 and form additional interactions, stabilizing the active conformation of VDR. In addition, 1,4α,25D3 and 1,4β,25D3 are as potent as 1,25D3 in regulating the expression of VDR target genes in rat intestinal epithelial cells and in the mouse kidney. Moreover, these two 4-hydroxy derivatives promote hypercalcemia in mice at a dose similar to that of the parent compound.

Keywords: calcemia; structure–function; synthesis; vitamin D metabolites.

MeSH terms

  • Animals
  • Calcitriol / analogs & derivatives
  • Calcitriol / chemical synthesis
  • Calcitriol / chemistry
  • Calcitriol / metabolism
  • Hypercalcemia / metabolism
  • Kidney / metabolism
  • Male
  • Mice
  • Rats
  • Receptors, Calcitriol* / chemistry
  • Receptors, Calcitriol* / genetics
  • Receptors, Calcitriol* / metabolism
  • Structure-Activity Relationship
  • Vitamin D / analogs & derivatives
  • Vitamin D / chemistry
  • Vitamin D / metabolism

Substances

  • Receptors, Calcitriol
  • Calcitriol
  • Vitamin D
  • dihydroxy-vitamin D3

Grants and funding

This research was supported by the French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INBS-05], Instruct-ERIC, and Agence Nationale de la Recherche under the program Investissements d’Avenir [ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02].